Table 1 Background information of study participants of Jordanian women, AL-Karak, 2022
Attribute | Frequency | % |
|---|---|---|
Marital Status | ||
Single | 213 | 51.4 |
Married | 189 | 45.7 |
Divorced/Widow | 12 | 2.9 |
Contraception method used | ||
Hormonal | 19 | 9.8 |
IUCDs | 18 | 9.3 |
Natural Method | 32 | 16.5 |
None | 125 | 64.4 |
Menstruation status | ||
Irregular | 43 | 10.4 |
Menopause | 38 | 9.2 |
Regular no primary dysmenorrhea | 68 | 16.4 |
Regular primary dysmenorrhea | 265 | 64 |
Medical history | ||
History of chronic diseases | 66 | 16 |
Medically free | 347 | 84 |
Use of Anticoagulants | ||
No | 400 | 96.6 |
Yes | 14 | 3.4 |
History of COVID-19 Infection | ||
Yes, I got the infection | 126 | 30.4 |
No, I did not get infected | 288 | 69.6 |
Symptoms during the period after the infection (n = 29 participants) | ||
None | 99 | 77.3 |
Heavy MC | 5 | 3.9 |
Intermenstrual bleeding | 1 | 17.2 |
Irregular MC | 8 | 3.4 |
Dysmenorrhea | 7 | 27.6 |
Light MC | 7 | 24.1 |
Post-menopausal bleeding | 1 | 24.1 |
COVID-19 vaccine type | ||
Pfizer | 244 | 58.9 |
Astrazeneca | 7 | 1.7 |
Sinopharm | 162 | 39.1 |
Sputnik | 1 | 0.2 |